Show simple item record

dc.contributor.authorRichardson, Sarah J.
dc.contributor.authorLeete, Pia
dc.contributor.authorBone, AJ
dc.contributor.authorFoulis, Alan K.
dc.contributor.authorMorgan, Noel G.
dc.date.accessioned2013-10-17T11:27:53Z
dc.date.issued2012-10-14
dc.description.abstractImmunohistochemical staining reveals that the enteroviral capsid protein VP1 is present at higher frequency in the insulin-containing islets of patients with recent-onset type 1 diabetes than in controls. This is consistent with epidemiological evidence suggesting that enteroviral infection may contribute to the autoimmune response in type 1 diabetes. However, immunostaining of VP1 is not definitive since the antibody widely used to detect the protein (Clone 5D8/1) might also cross-react with additional proteins under some conditions. Therefore, we sought to verify that VP1 immunopositivity correlates with additional markers of viral infection.en_GB
dc.identifier.citationVol. 56, Issue 1, pp. 185 - 193en_GB
dc.identifier.doi10.1007/s00125-012-2745-4
dc.identifier.urihttp://hdl.handle.net/10871/13816
dc.language.isoenen_GB
dc.publisherSpringer Verlagen_GB
dc.relation.urlhttp://www.ncbi.nlm.nih.gov/pubmed/23064357en_GB
dc.rights.embargoreasonPublisher’s policy
dc.titleExpression of the enteroviral capsid protein VP1 in the islet cells of patients with type 1 diabetes is associated with induction of protein kinase R and downregulation of Mcl-1en_GB
dc.typeArticleen_GB
dc.date.available2014-01-01T04:00:12Z
dc.identifier.issn0012-186X
dc.descriptionThe final publication is available at https://doi.org/10.1007/s00125-012-2745-4en_GB
dc.identifier.journalDiabetologiaen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record